A synthetic mRNA therapy successfully regenerated uterine lining in clinical trials, engineering pathways to restore ovarian function in aging populations, as reported on September 8, 2025.

Studies on cellular senescence removal in mice achieved a 35% improvement in outcomes, highlighting potential for human applications. This breakthrough focuses on clearing 'zombie cells' to enhance healthspan. It was shared as part of emerging longevity strategies.